National Clinical Coding Standards OPCS-4 (2017)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Lower Gastrointestinal Bleeding
Journal of Experimental and Clinical Medicine https://dergipark.org.tr/omuJecm Re view Article J Exp Clin Med 2021; 38(S1): 23-32 doi: 10.52142/omujecm.38.si.gastro.3 Lower gastrointestinal bleeding Serkan ÖCAL1,* , Mehmet Mutlu ÇATLI2 1 Department of Gastroenterology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey 2Departmant of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey Received: 13.12.2020 • Accepted/Published Online: 09.01.2021 • Final Version: 18.03.2021 Abstract Bleeding from the lower part of the digestive system that appears as hematocheZia (fresh blood, clot or cherry-colored stool) or melena (dark- colored tarry stool) is called lower gastrointestinal tract bleeding (lower GI bleeding) (or colonic bleeding). In the traditional definition, lower GI bleeding was generally classified as bleeding distal to the TreitZ ligament (duodenojejunal junction) as the border. In the last decade, GI bleeding has adopted three categories in some recent publications: Upper, middle, and lower. According to this category, bleeding from a source between the TreitZ ligament and the ileocecal valve is classified as middle GI bleeding, bleeding from the distal of the ileocecal valve is classified lower GI bleeding. Lower GI bleeding and hospitalization rates increase with aging. Currently, physicians managing lower GI bleeding have many different diagnostic and therapeutic options ranging from colonoscopy and flexible sigmoidoscopy to radiographic interventions such as scintigraphy or angiography. Lower GI bleeding often stops spontaneously and less common than upper GI bleeding. Even though no modality has emerged as the gold standard in the treatment of lower GI bleeding, colonoscopy has several advantages and is generally considered as the preferred initial test in most of the cases. -
Move Your Wheelchair with Your Eyes
International Journal of Applied Mathematics, Advanced Technology and Science Electronics and Computers ISSN:2147-82282147-6799 www.atscience.org/IJAMEC Original Research Paper Move Your Wheelchair with Your Eyes Gökçen ÇETİNEL*1, Sevda GÜL2, Zafer TİRYAKİ3, Enes KUZU4, Meltem MİLLİGÜNEY5 Accepted : 12/05/2017 Published: 21/08/2017 DOI: 10.18100/ijamec.2017Special Issue30462 Abstract: In the proposed study, our goal is to move paralyzed people with their eyes. Otherwise, use this document as an instruction set. Paper titles should be written in uppercase and lowercase letters, not all uppercase. For this purpose, we use their Electrooculogram (EOG) signals obtained from EOG goggles completely designed by the authors. Through designed EOG goggles, vertical-horizontal eye movements and voluntary blink detection are verified by using 5 Ag-AgCl electrodes located around the eyes. EOG signals utilized to control wheelchair motion by applying signal processing techniques. The main steps of signal processing phase are pre-processing, maximum-minimum value detection and classification, respectively. At first, pre-processing step is used to amplify and smooth EOG signals. In maximum-minimum value detection we obtain maximum and minimum voltage levels of the eye movements. Furthermore, we determine the peak time of blink to distinguish voluntary blinks from involuntary blinks. Finally, at classification step k-Nearest Neighbouring (k-NN) technique is applied to separate eye movement signals from each other. Several computer simulations are performed to show the effectiveness of the proposed EOG based wheelchair control system. According to the results, proposed system can communicate paralyzed people with their wheelchair and by this way they will be able to move by their selves. -
Outpatient Services
Outpatient Services Coverage of Certain Services in the OUTPATIENT setting only* EFFECTIVE MARCH 9, 2015 bmchp.org | 888-566-0008 TO FIND A CODE OR WORD - While holding down the CTRL key, press the F key, type in Code, then press ENTER key Procedure Code Description 0213T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; single level 0214T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; second level (List separately in addition to code for primary procedure) 0215T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; third and any additional level(s) (List separately in addition to code for primary procedure) 0216T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; single level 0217T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; second level (List separately in addition to code for primary procedure) 0218T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound -
UB04 Hospital Billing Instructions & Revenue Code Matrix
Maryland Department of Health Medical Assistance UB04 Hospital Billing Instructions & Revenue Code Matrix Revised 11/2017 Medical Assistance Problem Resolution Institutional Hotline: 410-767-5457 Nevis Smith, Division Chief, MAPR UB04 Hospital Instructions TABLE of CONTENTS Introduction 7 Electronic Verification System (EVS) 9 Sample UB04 11 UB04 FORM LOCATORS FL 01 Billing Provider Name, Address, and Telephone Number 12 FL 02 Pay-to Name and Address 12 FL 03a Patient Control Number 12 FL 03b Medical/Health Record Number 12 FL 04 Type of Bill 12 FL 05 Federal Tax No 17 FL 06 Statement Covers Period (From - Through) 17 FL 07 Reserved for Assignment by NUBC 17 FL 08 Patient Name – Identifier 18 FL 09 Patient address, city, State, zip code, and county code 18 FL 10 Patient Birth Date 18 FL 11 Patient Sex 18 FL 12 Admission/Start of Care Date 18 FL 13 Admission Hour 18 FL 14 Priority (Type) of Visit 19 FL 15 Source of Referral for Admission or Visit 19 FL 16 Discharge Hour 21 FL 17 Patient Status 21 FL 18-28 Condition Codes 23 FL 29 Accident State 32 FL 30 Reserved for Assignment by NUBC 32 FL 31-34 Occurrence Codes and Dates 32 FL 35-36 Occurrence Span Codes and Dates 36 FL 37 NOT USED 38 FL 38 Responsible party name and address 38 FL 39-41 Value Codes and Amounts 38 FL 42 Revenue Codes 42 FL 43 National Drug Code (NDC) Reporting 43 FL 44 HCPCS/Accommodation Rates/HIPPS Rate Codes 45 (HCPCS & HIV Testing Instructions) 45 FL 45 Service Date 46 FL 46 Units of Service 46 FL 47 Total Charges 46 FL 48 Non-Covered Charges 47 FL 49 Reserved for -
Electroretinography 1 Electroretinography
Electroretinography 1 Electroretinography Electroretinography measures the electrical responses of various cell types in the retina, including the photoreceptors (rods and cones), inner retinal cells (bipolar and amacrine cells), and the ganglion cells. Electrodes are usually placed on the cornea and the skin near the eye, although it is possible to record the ERG from skin electrodes. During a recording, the patient's eyes are exposed to standardized stimuli and the resulting signal is displayed showing the time course of the signal's Maximal response ERG waveform from a dark adapted eye. amplitude (voltage). Signals are very small, and typically are measured in microvolts or nanovolts. The ERG is composed of electrical potentials contributed by different cell types within the retina, and the stimulus conditions (flash or pattern stimulus, whether a background light is present, and the colors of the stimulus and background) can elicit stronger response from certain components. If a flash ERG is performed on a dark-adapted eye, the response is primarily from the rod system and flash ERGs performed on a light adapted eye will reflect the activity of the cone system. To sufficiently bright flashes, the ERG will contain an A patient undergoing an electroretinogram a-wave (initial negative deflection) followed by a b-wave (positive deflection). The leading edge of the a-wave is produced by the photoreceptors, while the remainder of the wave is produced by a mixture of cells including photoreceptors, bipolar, amacrine, and Muller cells or Muller glia.[1] The pattern ERG, evoked by an alternating checkerboard stimulus, primarily reflects activity of retinal ganglion cells. -
Flexible Video-Endsocopic Injection Sclerotherapy for Second and Third Degree Internal Hemorrhoids
Published online: 2019-09-26 ORIGINAL ARTICLE Flexible Video-Endsocopic Injection Sclerotherapy for Second and Third Degree Internal Hemorrhoids Sandeep Nijhawan, Udawat H, Gaurav Gupta, Anil Sharma, Amit Mathur, Bharat Sapra, Subhash Nepalia Department of Gastroenterology, SMS Medical College, Jaipur, Rajasthan, India ABSTRACT Background and objectives: Bleeding from hemorrhoids is the commonest cause of rectal bleeding in adults. Injection sclerotherapy of internal hemorrhoids is one of the non-surgical treatments, and is simple, safe and feasible. Conventionally sclerotherapy is performed with rigid proctoscope which has limitations of maneuverability, narrower field of vision and documentation compared to flexible videoendoscope. Therefore, we assessed the efficacy and safety of video-colonoscopic sclerotherapy for bleeding internal hemorrhides. Methods: Seventy-nine patients of bleeding internal hemorrhoids were subjected to colonoscopic sclerotherapy using 1.5% polidocanol in retroflexed or forward viewing positions. Success of treatment was defined as cessation of bleeding for six weeks. Patients were observed for complications and were followed up regularly for 3 months. Results: A total of 79 evaluable patients, 61 had grade II and 18 had grade III hemorrhoids. There was no statistically significant differences in achieving excellent or good results for control of bleeding between patients with grade II and grade III hemorrhoids (100% vs 94,5%; p>0.05). The number of sessions of sclerotherapy required were significantly more in grade II than grade III hemorrhoids (1.1 ± 0.3 vs 1.3 ± 0.7; p = 0.04). No significant complications were noted except for bloating in ten patients (12.6 %) and rectal pain in 6 (7.6%) patients. -
Maryland PBHS Provider Billing Appendix
Maryland PBHS Provider Billing Appendix 1. Billing Appendix Overview This Maryland PBHS Provider Billing Appendix (Billing Appendix) is included in the Optum Maryland Provider Manual by reference in section 13 Claim Submission. Note: Information contained in this Billing Appendix may be periodically updated or further explained through Provider Alerts. 2. General Claim Submission Guidelines Claims may be submitted online using Incedo Provider Portal (formerly known as Provider Connect), through a clearinghouse using Electronic Data Interchange (EDI) with 837batch files or by U.S. Mail. Online and Electronic Claim Submission For Incedo Provider Portal: After logging into Incedo Provider Portal, use the Incedo Provider Portal User Guide for instructions on entering a claim or for submitting an electronic file of claims. The link to the Incedo Provider Portal guide is found at maryland.optum.com > Behavioral Health Providers. For EDI/Electronic claims: Electronic Data Interchange (EDI) is the exchange of information for routine business transactions in a standardized computer format; for example, data interchange between a practitioner (physician, psychologist, social worker) and a payer. You may choose any clearinghouse vendor to submit claims using EDI. For PBHS claim submissions, use Payer ID OMDBH. The link to the 837i and 837p companion guides is maryland.optum.com Paper Claim Submission For U.S. Mail (paper claims): Optum Maryland will accept paper CMS-1500 forms for practitioner/professional services or Uniform Billing (UB)-04 forms for inpatient and outpatient facility claims. The mailing address for completed claim forms and required attachments is: Optum Maryland P.O. Box 30531 Salt Lake City, UT 84130 1 | P a g e BH2536_Billing Appendix 122019 Optum Maryland Please see the section on Paper claim submission for more specific instructions for use of CMS-1500 and UB-04 claim forms. -
Assessment and Management of Infantile Nystagmus Syndrome
perim Ex en l & ta a l ic O p in l h t C h f Journal of Clinical & Experimental a o l m l a o n l r o Atilla, J Clin Exp Ophthalmol 2016, 7:2 g u y o J Ophthalmology 10.4172/2155-9570.1000550 ISSN: 2155-9570 DOI: Review Article Open Access Assessment and Management of Infantile Nystagmus Syndrome Huban Atilla* Department of Ophthalmology, Faculty of Medicine, Ankara University, Turkey *Corresponding author: Huban Atilla, Department of Ophthalmology, Faculty of Medicine, Ankara University, Turkey, Tel: +90 312 4462345; E-mail: [email protected] Received date: March 08, 2016; Accepted date: April 26, 2016; Published date: April 29, 2016 Copyright: © 2016 Atilla H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract This article is a review of infantile nystagmus syndrome, presenting with an overview of the physiological nystagmus and the etiology, symptoms, clinical evaluation and treatment options. Keywords: Nystagmus syndrome; Physiologic nystagmus phases; active following of the stimulus results in poor correspondence between eye position and stimulus position. At higher velocity targets Introduction (greater than 100 deg/sec) optokinetic nystagmus can no longer be evoked. Unlike simple foveal smooth pursuit, OKN appears to have Nystagmus is a rhythmic, involuntary oscillation of one or both both foveal and peripheral retinal components [3]. Slow phase of the eyes. There are various classifications of nystagmus according to the nystagmus is for following the target and the fast phase is for re- age of onset, etiology, waveform and other characteristics. -
Assessing Ocular Activity During Performance of Motor Skills Using Electrooculography Gallicchio, Germano; Cooke, Andrew; Ring, Christopher
University of Birmingham Assessing ocular activity during performance of motor skills using electrooculography Gallicchio, Germano; Cooke, Andrew; Ring, Christopher DOI: 10.1111/psyp.13070 License: Creative Commons: Attribution (CC BY) Document Version Publisher's PDF, also known as Version of record Citation for published version (Harvard): Gallicchio, G, Cooke, A & Ring, C 2018, 'Assessing ocular activity during performance of motor skills using electrooculography', Psychophysiology. https://doi.org/10.1111/psyp.13070 Link to publication on Research at Birmingham portal General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document. When citing, please reference the published version. Take down policy While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been uploaded in error or has been deemed to be commercially or otherwise sensitive. -
National Clinical Coding Standards OPCS-4 (2018)
OPCS Classification of Interventions and Procedures Version 4.8 OPCS Classification of Interventions and Procedures Volume I - Tabular List I - Tabular Volume National Clinical Coding Standards OPCS-4 (2018) For more information please visit: Accurate data for quality information systems.digital.nhs.uk/data/clinicalcoding ISBN 978-0-11-323048-8 Terminology and Classifications Delivery Service www.tso.co.uk 9 780113 230488 9923 OPCS 4.8 Vol I Cover v0_2.indd 1-3 31/10/2016 10:00 National Clinical Coding Standards OPCS-4 Accurate data for quality information Produced by: Terminology and Classifications Delivery Service NHS Digital Vantage House 40 Aire Street Leeds LS1 4HT [email protected] http://systems.digital.nhs.uk/data/clinicalcoding Date of issue: April 2018 Copyright © 2018 Health and Social Care Information Centre The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital. OPCS-4 CONTENTS Introduction ............................................................................................................................ 3 Data Quality ........................................................................................................................... 7 National Clinical Coding Standards OPCS-4 reference book .............................................. 11 Rules of OPCS-4 ................................................................................................................. 16 Conventions of OPCS-4 ..................................................................................................... -
Eye Care Documentation Template Documentation Tem- Plate: Conceptual Structure
Eye Care Documentation Template Documentation Tem- plate: Conceptual Structure Contract: VA118-16-D-1008, Task Order (TO): VA-118-16-F-1008-0007, CLIN0009DA Department of Veterans Affairs (VA) Knowledge Based Systems (KBS) Office of Informatics and Information Governance (OIIG) Clinical Decision Support (CDS) Publication date 06/23/2018 Version: 1.0 Eye Care Documentation Template: Documentation Template: Con- ceptual Structure by Knowledge Based Systems (KBS), Office of Informatics and Information Governance (OIIG), and Clinical Deci- sion Support (CDS) Publication date 06/23/2018 Copyright © 2018 B3 Group, Inc. Copyright © 2018 Cognitive Medical Systems, Inc. B3 Group, Inc. NOTICE OF GOVERNMENT COPYRIGHT LICENSE AND UNLIMITED RIGHTS LICENSE Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. Portions of this content are derivative works from content produced by Cognitive Medical Systems, Inc. licensed under the Apache License, Version 2.0. Additional portions of this content are derivative works from content contributed by Motive Medical Intelligence Inc., under Creative Commons Attribution-ShareAlike 4.0. Contributions from 2013-2018 were performed either by US Government employees, or under US Veterans Health Administration contracts. US Veterans Health Administration contributions by government employees are work of the U.S. -
Electrooculography”
ISSN (Print) : 2319-5940 ISSN (Online) : 2278-1021 International Journal of Advanced Research in Computer and Communication Engineering Vol. 2, Issue 11, November 2013 An Overview of “Electrooculography” Uzma Siddiqui1, A.N Shaikh2 EC Department, Savitribai Phule Women’s Engineering College, Aurangabad MH, India 1 EC Department, Savitribai Phule Women’s Engineering College, Aurangabad MH, India 2 Abstract: This paper brings out a new technology of placing electrodes on user’s forehead around the eyes to record eye movements which is called as Electrooculography (EOG. This technology is based on the principle of recording the polarization potential or corneal-retinal potential (CRP), which is the resting potential between the cornea and the retina. This potential is commonly known as electrooculogram. is a very small electrical potential that can be detected using electrodes which is linearly proportional to eye displacement. EOG serves as a means of control for allowing the handicapped, especially those with only eye-motor coordination, to live more independent lives. This is a low cost assistive system for disabled people. The total command control based on EOG permits users to guide it with a enough degree of comfort ability. Keywords:AnalogDigitalConverter(ADC),Electroencefalogram(EEG),Electromyalgy(EMG),Electrooculography (EOG), Rapid Eye Movement(REM),Slow eye movement(SEM). I. INTRODUCTION Electrooculography is a technique for measuring the resting potential of the retina. The resulting signal is called the electrooculogram. An electrooculograph is a device that measures the voltage between two electrodes placed on the face of a subject so it can detect eye movement. Today the use of computers is extended to every field.